Research
& Development
Science-DrivenInnovationfor Tomorrow's Therapeutics
At Cannex, research is not a department — it's the foundation of everything we do. We believe that advancing the future of medical cannabis starts with asking the right questions, investing in the right partnerships, and upholding the same scientific rigor demanded of pharmaceutical products.
Our R&D ecosystem bridges cutting-edge science from Japan, clinical collaboration in Thailand, and product innovation that meets the regulatory standards of the world's most demanding medical markets.
Our Core
Focus Areas
Our Core
Focus Areas
1
Cannabinoid Innovation
Water-soluble CBD for increased bioavailability in beverages and oral forms
Pure THC isolation using preparative chromatography
Minor cannabinoid separation, such as CBG, CBN, CBC, for targeted effects
Cannabinoid-terpene matching to enhance therapeutic outcomes
2
Formulation Development
Custom ratios for tinctures, gummies, soft gels, vapes
Product development guided by clinical use cases and global compliance
Terpene profile design for efficacy and flavor control
3
Delivery Systems & Packaging
Dose-consistent delivery (sublingual, vapor, topical)
Stability testing for export conditions (heat, humidity)
Secure packaging for traceability and patient safety
Scientific Collaboration
We partner with:
Thai universities and medical institutes
for preclinical studies, lab testing, and pilot trials
Japanese chemical companies
for advanced separation, formulation, and THC remediation
International medical brands
co-developing patient-ready products for export
From lab bench to pharmacy shelf, Cannex is building cannabis products that are safe, predictable, and backed by science.
We welcome collaborations with researchers, hospitals, and wellness innovators around the world.
Interested in co-developing
your next cannabinoid solution?